EPB41L3
Band 4.1-like protein 3 is a protein that in humans is encoded by the EPB41L3 gene.[1][2][3]
Interactions
EPB41L3 has been shown to interact with YWHAB,[4][5] YWHAH,[5] YWHAG[4][5] and Cell adhesion molecule 1.[6]
References
- ↑ Peters LL, Weier HU, Walensky LD, Snyder SH, Parra M, Mohandas N, Conboy JG (Dec 1998). "Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human". Genomics 54 (2): 348–50. doi:10.1006/geno.1998.5537. PMID 9828140.
- ↑ Tran YK, Bögler O, Gorse KM, Wieland I, Green MR, Newsham IF (Jan 1999). "A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer". Cancer Research 59 (1): 35–43. PMID 9892180.
- ↑ "Entrez Gene: EPB41L3 erythrocyte membrane protein band 4.1-like 3".
- 1 2 Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D (2007). "Large-scale mapping of human protein-protein interactions by mass spectrometry". Molecular Systems Biology 3 (1): 89. doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.
- 1 2 3 Yu T, Robb VA, Singh V, Gutmann DH, Newsham IF (Aug 2002). "The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins". The Biochemical Journal 365 (Pt 3): 783–9. doi:10.1042/BJ20020060. PMC 1222735. PMID 11996670.
- ↑ Yageta M, Kuramochi M, Masuda M, Fukami T, Fukuhara H, Maruyama T, Shibuya M, Murakami Y (Sep 2002). "Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer". Cancer Research 62 (18): 5129–33. PMID 12234973.
Further reading
- Calinisan V, Gravem D, Chen RP, Brittin S, Mohandas N, Lecomte MC, Gascard P (2006). "New insights into potential functions for the protein 4.1 superfamily of proteins in kidney epithelium". Frontiers in Bioscience 11: 1646–66. doi:10.2741/1911. PMID 16368544.
- Adams MD, Kerlavage AR, Fleischmann RD, Fuldner RA, Bult CJ, Lee NH, Kirkness EF, Weinstock KG, Gocayne JD, White O (Sep 1995). "Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence" (PDF). Nature 377 (6547 Suppl): 3–174. PMID 7566098.
- Adams MD, Soares MB, Kerlavage AR, Fields C, Venter JC (Aug 1993). "Rapid cDNA sequencing (expressed sequence tags) from a directionally cloned human infant brain cDNA library". Nature Genetics 4 (4): 373–80. doi:10.1038/ng0893-373. PMID 8401585.
- Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O (Feb 1999). "Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro". DNA Research 6 (1): 63–70. doi:10.1093/dnares/6.1.63. PMID 10231032.
- Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, Kittiniyom K, Rempel SA, Gutierrez JA, Newsham IF (Jun 2000). "Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas". Human Molecular Genetics 9 (10): 1495–500. doi:10.1093/hmg/9.10.1495. PMID 10888600.
- Yu T, Robb VA, Singh V, Gutmann DH, Newsham IF (Aug 2002). "The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins". The Biochemical Journal 365 (Pt 3): 783–9. doi:10.1042/BJ20020060. PMC 1222735. PMID 11996670.
- Charboneau AL, Singh V, Yu T, Newsham IF (Jul 2002). "Suppression of growth and increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer cells". International Journal of Cancer. Journal International Du Cancer 100 (2): 181–8. doi:10.1002/ijc.10470. PMID 12115567.
- Yageta M, Kuramochi M, Masuda M, Fukami T, Fukuhara H, Maruyama T, Shibuya M, Murakami Y (Sep 2002). "Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer". Cancer Research 62 (18): 5129–33. PMID 12234973.
- Nakayama M, Kikuno R, Ohara O (Nov 2002). "Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs". Genome Research 12 (11): 1773–84. doi:10.1101/gr.406902. PMC 187542. PMID 12421765.
- Heinrich B, Hartmann C, Stemmer-Rachamimov AO, Louis DN, MacCollin M (Feb 2003). "Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms". International Journal of Cancer. Journal International Du Cancer 103 (4): 483–8. doi:10.1002/ijc.10840. PMID 12478663.
- Denisenko-Nehrbass N, Oguievetskaia K, Goutebroze L, Galvez T, Yamakawa H, Ohara O, Carnaud M, Girault JA (Jan 2003). "Protein 4.1B associates with both Caspr/paranodin and Caspr2 at paranodes and juxtaparanodes of myelinated fibres". The European Journal of Neuroscience 17 (2): 411–6. doi:10.1046/j.1460-9568.2003.02441.x. PMID 12542678.
- Robb VA, Li W, Gutmann DH (Apr 2004). "Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppression". Oncogene 23 (20): 3589–96. doi:10.1038/sj.onc.1207445. PMID 15116094.
- Kittiniyom K, Mastronardi M, Roemer M, Wells WA, Greenberg ER, Titus-Ernstoff L, Newsham IF (Jul 2004). "Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation". Genes, Chromosomes & Cancer 40 (3): 190–203. doi:10.1002/gcc.20034. PMID 15138999.
- Jin J, Smith FD, Stark C, Wells CD, Fawcett JP, Kulkarni S, Metalnikov P, O'Donnell P, Taylor P, Taylor L, Zougman A, Woodgett JR, Langeberg LK, Scott JD, Pawson T (Aug 2004). "Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization". Current Biology 14 (16): 1436–50. doi:10.1016/j.cub.2004.07.051. PMID 15324660.
- Singh V, Miranda TB, Jiang W, Frankel A, Roemer ME, Robb VA, Gutmann DH, Herschman HR, Clarke S, Newsham IF (Oct 2004). "DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo". Oncogene 23 (47): 7761–71. doi:10.1038/sj.onc.1208057. PMID 15334060.
- Ballif BA, Villén J, Beausoleil SA, Schwartz D, Gygi SP (Nov 2004). "Phosphoproteomic analysis of the developing mouse brain". Molecular & Cellular Proteomics 3 (11): 1093–101. doi:10.1074/mcp.M400085-MCP200. PMID 15345747.
|
This article is issued from Wikipedia - version of the Thursday, November 26, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.